You are here: Home > Clinical Trials & Research > Genitourinary Cancer
Genitourinary Cancer
| CALGB-90203 | Lead group: CALGB |
| A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer | |
| E2805 (ASSURE) | Lead group: ECOG |
| Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma | |
We participate in many NCI sponsored trials. Please feel free to contact Leann Ross at (304) 399-6617 or leann.ross@chhi.org or Barbara Payne at (304) 399-6637.
For more information about the clinical trials listed please go to http://www.clinicaltrials.gov.
Page last updated: 05/06/2008 | Recommend this page | Printer friendly version